83071 | 83071 | Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention | Completed | No Results Available | Osteoporosis | Dietary Supplement: Milk proteins fraction | https://ClinicalTrials.gov/show/NCT01478724 |
83072 | 83072 | Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants | Completed | No Results Available | Prematurity | Other: Clinical Decision Support Tool | https://ClinicalTrials.gov/show/NCT01478711 |
83073 | 83073 | The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients | Recruiting | No Results Available | Peritoneal Dialysis|Peritoneal Dialysis, Continuous Ambulatory | Drug: Tissue Plasminogen Activator (tPA)|Drug: recombinant deoxyribonuclease (DNase) | https://ClinicalTrials.gov/show/NCT01478698 |
83074 | 83074 | A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors | Active, not recruiting | No Results Available | Urinary Bladder Neoplasms|Carcinoma, Transitional Cell|Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms|Carcinoma, Non-Small-Cell Lung|Carcinoma, Pancreatic Ductal|Tumor Virus Infections | Drug: CC-486 plus Carboplatin|Drug: CC-486 plus ABI-007|Drug: CC-486 | https://ClinicalTrials.gov/show/NCT01478685 |
83075 | 83075 | Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten | Completed | No Results Available | Diabetes|Heart Disease|Quality of Life | Procedure: Health Coaching and Life-long Monitoring | https://ClinicalTrials.gov/show/NCT01478672 |
83076 | 83076 | The Effect of Fiber Snack Foods on Dietary Intake in Healthy Adults | Completed | No Results Available | Fructooligosaccharide | Dietary Supplement: Control study food with no added fiber|Dietary Supplement: Study food with added fiber | https://ClinicalTrials.gov/show/NCT01478659 |
83077 | 83077 | The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV | Completed | No Results Available | Chronic Obstructive Pulmonary Disease | Other: conventional breathing therapy|Other: reflectory breathing therapy | https://ClinicalTrials.gov/show/NCT01478646 |
83078 | 83078 | Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil | Completed | No Results Available | Alzheimer's Disease | Drug: Galantamine | https://ClinicalTrials.gov/show/NCT01478633 |
83079 | 83079 | Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI) | Completed | Has Results | Urinary Tract Infection | Drug: Canephron® N | https://ClinicalTrials.gov/show/NCT01478620 |
83080 | 83080 | A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients | Completed | No Results Available | Painful Diabetic Peripheral Neuropathy (PDPN) | Drug: QUTENZA | https://ClinicalTrials.gov/show/NCT01478607 |
83081 | 83081 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | Completed | Has Results | Colorectal Cancer | Drug: Tivozanib|Drug: Bevacizumab|Drug: mFOLFOX6 | https://ClinicalTrials.gov/show/NCT01478594 |
83082 | 83082 | Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma | Active, not recruiting | No Results Available | Multiple Myeloma | Drug: PCI-32765|Drug: Dexamethasone | https://ClinicalTrials.gov/show/NCT01478581 |
83083 | 83083 | To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together | Completed | No Results Available | Pharmacokinetics of Mirabegron|Healthy Subjects | Drug: mirabegron|Drug: desipramine | https://ClinicalTrials.gov/show/NCT01478568 |
83084 | 83084 | A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease | Not yet recruiting | No Results Available | Dry Eye Disease | Drug: ISV 101 | https://ClinicalTrials.gov/show/NCT01478555 |
83085 | 83085 | OPTIMAL>60, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine | Recruiting | No Results Available | CD20+ Aggressive B-Cell Lymphoma | Drug: Conventional Vincristine|Drug: Liposomal Vincristine|Drug: Ricover-scheme rituximab|Drug: optimised rituximab-schedule | https://ClinicalTrials.gov/show/NCT01478542 |
83086 | 83086 | A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation | Completed | No Results Available | Pharmacokinetics of Mirabegron|Bioavailability|Healthy Subjects | Drug: mirabegron OCAS|Drug: mirabegron | https://ClinicalTrials.gov/show/NCT01478529 |
83087 | 83087 | Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy | Recruiting | No Results Available | Macular Edema | Procedure: Intravitreal injection | https://ClinicalTrials.gov/show/NCT01478516 |
83088 | 83088 | To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females | Completed | No Results Available | Pharmacokinetics|Healthy Subjects | Drug: mirabegron OCAS|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01478503 |
83089 | 83089 | To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol | Completed | No Results Available | Pharmacokinetics of Mirabegron|Healthy Subjects | Drug: mirabegron|Drug: metoprolol | https://ClinicalTrials.gov/show/NCT01478490 |
83090 | 83090 | Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole | Active, not recruiting | No Results Available | Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer | Dietary Supplement: omega-3 fatty acid supplement|Other: Placebo|Other: Clinical assessments|Other: Assessment of therapy complications|Procedure: Magnetic Resonance Imaging|Procedure: Correlative/special studies | https://ClinicalTrials.gov/show/NCT01478477 |
83091 | 83091 | Effect of Massage on Hamstring Muscle Soreness | Completed | No Results Available | Musculoskeletal Disorders | Other: Massage | https://ClinicalTrials.gov/show/NCT01478464 |
83092 | 83092 | Acute Effect of Massage and Exercise on Muscle Tenderness | Completed | No Results Available | Musculoskeletal Disorders | Behavioral: Exercise|Other: Massage | https://ClinicalTrials.gov/show/NCT01478451 |
83093 | 83093 | A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers | Active, not recruiting | No Results Available | Malignant Tumor | Device: Novilase Interstitial Laser Therapy | https://ClinicalTrials.gov/show/NCT01478438 |
83094 | 83094 | Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen | Completed | No Results Available | Allergic Rhinitis | Device: Lipidic Microemulsion|Device: Saline | https://ClinicalTrials.gov/show/NCT01478425 |
83095 | 83095 | An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer | Recruiting | No Results Available | Prostate Adenocarcinoma | Other: Polymer based fiducial placement | https://ClinicalTrials.gov/show/NCT01478412 |
83096 | 83096 | Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function | Completed | No Results Available | Diabetes Mellitus, Type 2 | Drug: PB1023 Injection | https://ClinicalTrials.gov/show/NCT01478399 |
83097 | 83097 | Effectiveness of a Knee Brace When Combined With Viscosupplementation in the Treatment of Knee Osteoarthritis | Terminated | No Results Available | Knee Osteoarthritis | Other: Orthovisc|Device: DonJoy HA lite knee brace|Device: Orthovisc injections and DonJoy HA lite knee brace | https://ClinicalTrials.gov/show/NCT01478386 |
83098 | 83098 | Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib | Completed | Has Results | Gastrointestinal Stromal Tumors | Drug: Dovitinib (TKI258) | https://ClinicalTrials.gov/show/NCT01478373 |
83099 | 83099 | Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma | Completed | No Results Available | Asthma | Drug: AIN457 (secukinumab)|Drug: Placebo | https://ClinicalTrials.gov/show/NCT01478360 |
83100 | 83100 | A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults | Completed | Has Results | Meningococcal Disease|Meningococcal Meningitis | Biological: Recombinant meningococcal B + OMV NZ | https://ClinicalTrials.gov/show/NCT01478347 |